Alto Neuroscience adds third Phase 3 trial for ALTO-207, cites Nature Medicine dataAug 12Quarterly updateAlto Neuroscience
Boehringer Ingelheim posts completed bioequivalence trial of two pramipexole tablet formulationsJul 27Trial updateBoehringer Ingelheimpramipexole
Sign inSign in